As of 2024-12-14, the Relative Valuation of Clovis Oncology Inc (CLVS) is (31.52) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 USD, the upside of Clovis Oncology Inc based on Relative Valuation is -38923.4%.
The range of the Relative Valuation is (24.53) - (36.94) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.4x - 24.4x | 15.4x |
| Forward P/E multiples | 13.4x - 20.2x | 19.2x |
| Fair Price | (24.53) - (36.94) | (31.52) |
| Upside | -30304.7% - -45586.9% | -38923.4% |
| Date | P/E |